Investigational approaches to therapies for idiopathic pulmonary fibrosis.
about
FcγRI mediates serum amyloid P inhibition of fibrocyte differentiationA review of current and novel therapies for idiopathic pulmonary fibrosisApolipoprotein A1 Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition of Alveolar Epithelial CellsLysophosphatidic acid-1-receptor targeting agents for fibrosis.
P2860
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@en
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@nl
type
label
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@en
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@nl
prefLabel
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@en
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@nl
P2860
P1476
Investigational approaches to therapies for idiopathic pulmonary fibrosis.
@en
P2093
Mark L Lupher
P2860
P304
P356
10.1517/13543784.2010.484018
P407
P577
2010-06-01T00:00:00Z